Paul Hopper has done it again!, page-3

it doesn't relate.
Another way to look at the Paul Hopper post is to note that for the last year or more both the companies involved with Hopper - IMU and PTX - have performed miserably. Talk of takeovers is nonsense.
What most posters don't understand is that big Pharma does not gamble. Name a single biotech stock with unproven science which has EVER been the subject of a big Pharma takeover. You won't find any. If big Pharma knows it will make a profit from a takeover subject because its science is proven then it has no difficulty paying $5 per share for the likes of a successful IMU coming up with a genuine cancer 'vaccine'.
It's only amateur punters who talk about takeovers in IMU's current context.